4Ma ZH,Lee SS. Cirrhotic Cardiopulmonary. getting to thc heart of the matters. Hepatology, 1996,14: 606- 608. 被引量：1
5Kelbaek H, Eriksen J, Brynjolf I, et al. Cardiac performance in patient with smptormatic alcoholic cirrhotic of the liver, AM J Cardio,1984,54(1) :852-855. 被引量：1
6Grose RD,Nolan J,Dillin JF,et al. Exercise-infuced left ventricular dysfunction in alcoholic and non- alcoholic cirrhosis. J Hepatol,1995,22(3):326-332. 被引量：1
7Rayes N,Beehstein WO, Keek H, et al. Cause of death after liver transplantation;a analysis of 41 cases in 382 patients. Zeatralbl Chir, 1995, 120(6): 435-438. 被引量：1
8Lee SS, Hadengue A, Moreau R,et al. Rostprandial hemodynamic responses in patient with cirrhosis. Hepatology, 1998,8(3) :647-651. 被引量：1
9Valeriano V, Funaro S, Lionetti R,et al. Modification of cardiac function in cirrhotic patients with and without ascites[J]. Am J Gastroenterol,2000,95:3200. 被引量：1
10Laffi G, Barletta G, Lavilla G, et al. Altered cardiovascnlar responsiveness to active tilting in nonalcoholic cirrhosis[J]. Gastroenterology, 1997,113:891. 被引量：1
6Matthews JC, Pagani FD, Haft JW, Koelling TM, Naftel DC, Aaronson KD. Model for end-stage liverdisease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010. 121:214-220 [PMID: 20048215 DOI: 10.1161/CIRCULATIONAHA]. 被引量：1
7Wieselthaler GM, O Driscoll G, Jansz P, KhaghaniA, Strueber M. Initial clinical experience with a novel left ventricular assist device with a magneti- cally levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010. 29:1218-1225 [PMID: 20646936 DOI: 10.1016/j.healun]. 被引量：1
